BioCryst Pharmaceuticals
The Director, Publication Strategy & Execution leads the strategy and implementation of the Publications plan as a senior leader within the Medical Affairs Extended Leadership Team. This role involves collaborating with cross-functional leaders to develop and execute medical and scientific publications across the hereditary angioedema and pipeline portfolio. The position requires managing vendor relationships, ensuring compliance with good publication practices, and overseeing the maintenance of publication planning documents.
Headquarters
Durham, North Carolina, United States
Company Size
501-1000 employees
Founded
1986
BioCryst Pharmaceuticals is a global biotech company with over three decades of experience in drug discovery, development, and commercialization, specializing in rare disease therapeutics. Founded in 1986, the company focuses on hereditary angioedema (HAE) and other rare diseases, delivering first-in-class or best-in-class oral small-molecule and injectable protein therapeutics. BioCryst uses a novel, structure-guided approach blending traditional biology and medicinal chemistry with advanced technologies to develop medicines for underserved patient communities worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioCryst Pharmaceuticals.
Director, Scientific Communications
kaileratherapeutics
Director Publications Strategy, asundexian
City of Duncan, Oklahoma
Senior Manager/Associate Director, Scientific Communications & Publications
Kura Oncology
Publication Lead
AstraZeneca
Sr. Director/ED, Medical Affairs Medical Communications Publications
Artiva Biotherapeutics
Associate Director, Medical Affairs – Publications - Contractor
Arcus Biosciences